EQR
54
3
CI
45
-3
GE
61
-3
STX
45
-4
TRIP
50
-4
WM
74
-5
MUR
44
-3
AAPL
40
-6
HCP
56
-8
TXN
43
-5
INTC
41
4
SHW
62
-6
KMX
61
-3
ETR
65
2
SWK
50
-5
KEY
43
-3
BBY
52
6
A
37
-2
CL
54
3
AVGO
18
-9
EQR
54
3
CI
45
-3
GE
61
-3
STX
45
-4
TRIP
50
-4
WM
74
-5
MUR
44
-3
AAPL
40
-6
HCP
56
-8
TXN
43
-5
INTC
41
4
SHW
62
-6
KMX
61
-3
ETR
65
2
SWK
50
-5
KEY
43
-3
BBY
52
6
A
37
-2
CL
54
3
AVGO
18
-9
Financhill
Back

Scandinavian Tobacco Group AS Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
13

STBGY
Scandinavian Tobacco Group AS

Last Price:
7.16
Seasonality Move:
8.49%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
13
Scandinavian Tobacco Group AS (STBGY) is a Sell

Is Scandinavian Tobacco Group AS a Buy, Sell or Hold?

  • The current Scandinavian Tobacco Group AS [STBGY] share price is $7.16. The Score for STBGY is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • STBGY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

STBGY Stock Price Chart

What is Scandinavian Tobacco Group AS's stock price today?

  • The Scandinavian Tobacco Group AS share price today is $7.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STBGY is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

STBGY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 4.5 Sell
Chaikin Money Flow: 1000 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.55 - 7.79) Sell
Bollinger Bands (100): (7.3 - 7.72) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

STBGY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.55 Sell
20-day SMA: 7.65 Sell
50-day SMA: 7.64 Sell
200-day SMA: 7.84 Sell
8-day EMA: 7.51 Sell
20-day EMA: 7.61 Sell
50-day EMA: 7.62 Sell
200-day EMA: 7.88 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Scandinavian Tobacco Group AS Earnings Growth & STBGY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Scandinavian Tobacco Group AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):